Tofacitinib for the treatment of lichen planopilaris: A case series

Lichen planopilaris (LPP) is an inflammatory cicatricial alopecia for which many different therapies are attempted with varying success. The Janus kinase (JAK) inhibitor, tofacitinib, has been shown to be effective in treating the noncicatricial alopecia, alopecia areata. As in alopecia areata, upre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dermatologic therapy 2018-11, Vol.31 (6), p.e12656-n/a
Hauptverfasser:	Yang, Christine C., Khanna, Trisha, Sallee, Brigitte, Christiano, Angela M., Bordone, Lindsey A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged alopecia Alopecia - diagnosis Alopecia - drug therapy Alopecia - enzymology Dermatologic Agents - administration & dosage Dermatologic Agents - adverse effects Drug Administration Schedule Female frontal fibrosing alopecia Humans JAK inhibitors Janus Kinase Inhibitors - administration & dosage Janus Kinase Inhibitors - adverse effects lichen planopilaris Lichen Planus - diagnosis Lichen Planus - drug therapy Lichen Planus - enzymology Male Middle Aged Piperidines - administration & dosage Piperidines - adverse effects Pyrimidines - administration & dosage Pyrimidines - adverse effects Pyrroles - administration & dosage Pyrroles - adverse effects Remission Induction Retrospective Studies Scalp Scalp Dermatoses - diagnosis Scalp Dermatoses - drug therapy Scalp Dermatoses - enzymology scarring alopecia Skin - drug effects Skin - enzymology Skin - pathology Therapeutic Hotline: Short Paper Therapeutic Hotline: Short Papers Time Factors tofacitinib Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!